Evidence map›Paper›PMID 30120788›Full record

ArticleJournal of the science of food and agriculture2019

A novel enzymatic method for the measurement of lactose in lactose-free products.

David Mangan, Barry V McCleary, Helena Culleton, Claudio Cornaggia, Ruth Ivory, Vincent A McKie, Elaine Delaney, Tadas Kargelis

Open access · hybridAbstract readEvaluation Study
In one paragraph

Article in Journal of the science of food and agriculture, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Efficient Production of Broad-Spectrum Antimicrobials byFrontiers in bioengineering and biotechnology · 2022
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

David ManganMegazyme u.c., IDA Business Park, Southern Cross Road, Bray, Co. Wicklow, Ireland.ORCID https://orcid.org/0000-0002-8884-478X
Barry V McClearyMegazyme u.c., IDA Business Park, Southern Cross Road, Bray, Co. Wicklow, Ireland.
Helena CulletonMegazyme u.c., IDA Business Park, Southern Cross Road, Bray, Co. Wicklow, Ireland.
Claudio CornaggiaMegazyme u.c., IDA Business Park, Southern Cross Road, Bray, Co. Wicklow, Ireland.
Ruth IvoryMegazyme u.c., IDA Business Park, Southern Cross Road, Bray, Co. Wicklow, Ireland.
Vincent A McKieMegazyme u.c., IDA Business Park, Southern Cross Road, Bray, Co. Wicklow, Ireland.
Elaine DelaneyMegazyme u.c., IDA Business Park, Southern Cross Road, Bray, Co. Wicklow, Ireland.
Tadas KargelisMegazyme u.c., IDA Business Park, Southern Cross Road, Bray, Co. Wicklow, Ireland.
Ultizyme International (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn recent years there has been a surge in the number of commercially available lactose-free variants of a wide variety of products. This presents an analytical challenge for the measurement of the residual lactose content in the presence of high levels of mono-, di-, and oligosaccharides.

resultsIn the current work, we describe the development of a novel enzymatic low-lactose determination method termed LOLAC (low lactose), which is based on an optimized glucose removal pre-treatment step followed by a sequential enzymatic assay that measures residual glucose and lactose in a single cuvette. Sensitivity was improved over existing enzymatic lactose assays through the extension of the typical glucose detection biochemical pathway to amplify the signal response. Selectivity for lactose in the presence of structurally similar oligosaccharides was provided by using a β-galactosidase with much improved selectivity over the analytical industry standards from Aspergillus oryzae and Escherichia coli (EcLacZ), coupled with a 'creep' calculation adjustment to account for any overestimation. The resulting enzymatic method was fully characterized in terms of its linear range (2.3-113 mg per 100 g), limit of detection (LOD) (0.13 mg per 100 g), limit of quantification (LOQ) (0.44 mg per 100 g) and reproducibility (≤ 3.2% coefficient of variation (CV)). A range of commercially available lactose-free samples were analyzed with spiking experiments and excellent recoveries were obtained. Lactose quantitation in lactose-free infant formula, a particularly challenging matrix, was carried out using the LOLAC method and the results compared favorably with those obtained from a United Kingdom Accreditation Service (UKAS) accredited laboratory employing quantitative high performance anion exchange chromatography - pulsed amperometric detection (HPAEC-PAD) analysis.

conclusionThe LOLAC assay is the first reported enzymatic method that accurately quantitates lactose in lactose-free samples. © 2018 The Authors. Journal of The Science of Food and Agriculture published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry.

Indexed as

beta-GalactosidaseBiocatalysisEnzyme AssaysFood ContaminationLactoseLimit of DetectionOligosaccharidesUnited Kingdombeta-GalactosidaseLactoseOligosaccharidesEnzymatic assayLactose determinationLactose-freeβ-Galactosidase

Identifiers

PMID30120788
PMCPMC6585930
OpenAlexW2886318628

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.